Zhou, Huaqiang

Reporting of Immune Checkpoint Inhibitor Therapy–Associated Diabetes, 2015–2019

Liu, J., Zhou, H., Zhang, Y., Fang, W., Yang, Y., Huang, Y., & Zhang, L. (2020) · Diabetes Care

Cancer Immunotherapy and BiomarkersPharmacovigilance and Adverse Drug Reactions

Cited by 55

Early change of plasma Epstein-Barr virus DNA load and the viral lytic genome level could positively predict clinical outcome in recurrent or metastatic nasopharyngeal carcinoma receiving anti-programmed cell death 1 monotherapy

Lin, S., Zhou, H., Chen, G., Xue, J., Liu, Q., Li, J., Yang, Y., Zhao, Y., Bao, H., Huang, Y., et al. (2024) · BMC Cancer

Viral-associated cancers and disordersHead and Neck Cancer Studies

Cited by 10